Skip to main content

Advertisement

Log in

Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Regular use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been hypothesized to be associated with reduced risk of non-Hodgkin lymphoma (NHL), although previous results have been inconsistent. The current study investigated the effects of regular aspirin or acetaminophen use on non-Hodgkin lymphoma risk among 625 individuals with primary, incident NHL and 2512 age and sex matched hospital controls with non-neoplastic conditions who completed a comprehensive epidemiologic questionnaire. Results indicate that regular aspirin use may be associated with decreased NHL risk among men [adjusted odds ratio (aOR) 0.82, 95% confidence interval (CI), 0.65–1.04], but not among women (aOR 0.93, 95% CI, 0.71–1.23). In contrast, regular acetaminophen use was associated with elevated NHL risk among women (aOR 1.71, 95% CI, 1.18–2.50) but not among men (aOR 0.75, 95% CI, 0.48–1.17). Other studies have demonstrated that acetaminophen is associated with transient decreases in DNA repair, and lymphocytes may be particularly susceptible to DNA damage, suggesting a mechanism for the elevated NHL risk observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. C Theodossiou P. Schwarzenberger (2002) ArticleTitleNon-Hodgkin’s lymphomas Clinical Obstetrics and Gynecology 45 820–829 Occurrence Handle10.1097/00003081-200209000-00029 Occurrence Handle12370624

    Article  PubMed  Google Scholar 

  2. SEER Cancer Statistics Review (1975–2004). Bethesda, MD: National Cancer Institute; 2004

  3. S Grufferman (1996) Epidemiology and hereditary aspects of malignant lymphoma and Hodgkin’s disease PH Wiernik GP Canellos JP Dutcher RA Kyle (Eds) Neoplastic Diseases of the Blood Churchill Livingstone Inc. New York

    Google Scholar 

  4. LJ Kinlen (1985) ArticleTitleIncidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment Am J Med 78 IssueID1A 44–49 Occurrence Handle10.1016/0002-9343(85)90245-1 Occurrence Handle1:STN:280:BiqC3MbivVI%3D

    Article  CAS  Google Scholar 

  5. HA Isomaki T Hakulinen U Joutsenlahti (1979) ArticleTitleLymphoma and rheumatoid arthritis (letter) Lancet 1 392 Occurrence Handle10.1016/S0140-6736(79)92942-8 Occurrence Handle1:STN:280:CSaC3sznvVw%3D

    Article  CAS  Google Scholar 

  6. E Baecklund A Ekbom P Sparen N Feltelius L Klareskog (1998) ArticleTitleDisease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study BMJ 317 IssueID7152 180–181 Occurrence Handle1:STN:280:DyaK1czjt1KltA%3D%3D Occurrence Handle9665898

    CAS  PubMed  Google Scholar 

  7. WP McWhorter (1988) ArticleTitleAllergy and risk of cancer. A prospective study using NHANESI followup data Cancer 62 IssueID2 451–455 Occurrence Handle1:STN:280:BieB2MzhsFM%3D Occurrence Handle3383143

    CAS  PubMed  Google Scholar 

  8. NC Briggs RS Levine EA Brann (2000) ArticleTitleAllergies and risk of non-Hodgkin’s lymphoma by subtype Cancer Epidemiol Biomarkers Prev 11 IssueID4 401–407

    Google Scholar 

  9. RA Cartwright PA McKinney C O’Brien ID Richards B Roberts I Lauder et al. (1988) ArticleTitleNon-Hodgkin’s lymphoma: case control epidemiological study in Yorkshire Leuk Res 12 IssueID1 81–88 Occurrence Handle10.1016/0145-2126(88)90111-7 Occurrence Handle1:STN:280:BieC1cfnsVU%3D Occurrence Handle3357350

    Article  CAS  PubMed  Google Scholar 

  10. K Zhu RS Levine EA Brann Y Gu LS Caplan I Hall et al. (2001) ArticleTitleRisk factors for non-Hodgkin’s lymphoma according to family history of haematolymphoproliferative malignancies Int J Epidemiol 30 IssueID4 818–824 Occurrence Handle10.1093/ije/30.4.818 Occurrence Handle1:STN:280:DC%2BD3MrhtlCquw%3D%3D Occurrence Handle11511610

    Article  CAS  PubMed  Google Scholar 

  11. JH Olsen G Schulgen JD Boice SuffixJr J Whysner LB Travis GM Williams et al. (1995) ArticleTitleAntiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma Cancer Res 55 IssueID2 294–297 Occurrence Handle1:CAS:528:DyaK2MXjtFyjsL0%3D Occurrence Handle7812960

    CAS  PubMed  Google Scholar 

  12. Li FP, Willard DR, Goodman R, Vawter G. Malignant lymphoma after diphenylhydantoin (dilantin) therapy. Cancer 36(4): 1359–1362

  13. Boffetta P, Kaldor JM. Secondary malignancies following cancer chemotherapy. Acta Oncol 33(6): 591–598

  14. HI Morrison K Wilkins R Semenciw Y Mao D Wigle (1992) ArticleTitleHerbicides and cancer J Natl Cancer Inst 84 IssueID24 1866–1874 Occurrence Handle1:STN:280:ByyD1Mrht1E%3D Occurrence Handle1460670

    CAS  PubMed  Google Scholar 

  15. HH McDuffie P Pahwa JR McLaughlin JJ Spinelli S Fincham JA Dosman et al. (2001) ArticleTitleNon-Hodgkin’s lymphoma and specific pesticide exposures in men: cross-Canada study of pesticides and health Cancer Epidemiol Biomarkers Prev 10 IssueID11 1155–1163 Occurrence Handle1:CAS:528:DC%2BD3MXptFWqu70%3D Occurrence Handle11700263

    CAS  PubMed  Google Scholar 

  16. JP Collet C Sharpe E Belzile JF Boivin J Hanley L Abenhaim (1998) ArticleTitleColorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing Br J Cancer 81 IssueID1 62–68 Occurrence Handle10.1038/sj.bjc.6690651

    Article  Google Scholar 

  17. L Rosenberg C Louik S Shapiro (1998) ArticleTitleNonsteroidal anti inflammatory drug use and reduced risk of large bowel carcinoma Cancer 82 IssueID12 2326–2333 Occurrence Handle10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q Occurrence Handle1:STN:280:DyaK1c3pslCntQ%3D%3D Occurrence Handle9635524

    Article  CAS  PubMed  Google Scholar 

  18. MJ Thun (1997) ArticleTitleAspirin and gastrointestinal cancer Adv Exp Med Biol 400 395–402

    Google Scholar 

  19. LJ Marnett (1995) ArticleTitleAspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer Prev Med 24 IssueID2 103–106 Occurrence Handle10.1006/pmed.1995.1017 Occurrence Handle1:STN:280:ByqA38%2Fht1I%3D Occurrence Handle7597006

    Article  CAS  PubMed  Google Scholar 

  20. DC Farrow TL Vaughan PD Hansten JL Stanford HA Risch MD Gammon et al. (1998) ArticleTitleUse of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer Cancer Epidemiol Biomarkers Prev 7 IssueID2 97–102

    Google Scholar 

  21. EM Funkhouser GB Sharp (1995) ArticleTitleAspirin and reduced risk of esophageal carcinoma Cancer 76 IssueID7 1116–1119 Occurrence Handle1:CAS:528:DyaK2MXptFOgtbk%3D Occurrence Handle8630885

    CAS  PubMed  Google Scholar 

  22. D Zaridze E Borisova D Maximovitch V Chkhikvadze (1999) ArticleTitleAspirin protects against gastric cancer: results of a case-control study from Moscow, Russia Int J Cancer 82 IssueID4 473–476 Occurrence Handle10.1002/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K Occurrence Handle1:CAS:528:DyaK1MXltVKqsbo%3D Occurrence Handle10404057

    Article  CAS  PubMed  Google Scholar 

  23. KB Moysich C Mettlin MS Piver N Natarajan RJ Menezes H Swede (2001) ArticleTitleRegular use of analgesic drugs and ovarian cancer risk Cancer Epidemiol Biomarkers Prev 10 IssueID8 903–906 Occurrence Handle1:STN:280:DC%2BD3Mvktlahuw%3D%3D Occurrence Handle11489759

    CAS  PubMed  Google Scholar 

  24. L Rosenberg JR Palmer RS Rao PF Coogan BL Strom AG Zauber et al. (2000) ArticleTitleA case-control study of analgesic use and ovarian cancer Cancer Epidemiol Biomarkers Prev 9 IssueID9 933–937 Occurrence Handle1:STN:280:DC%2BD3cvlt1Ggsg%3D%3D Occurrence Handle11008911

    CAS  PubMed  Google Scholar 

  25. A Akhmedkhanov P Toniolo A Zeleniuch-Jacquotte I Kato KL Koenig RE Shore (2001) ArticleTitleAspirin and epithelial ovarian cancer Prev Med 33 IssueID6 682–687 Occurrence Handle10.1006/pmed.2001.0945 Occurrence Handle1:CAS:528:DC%2BD3MXosFGht70%3D Occurrence Handle11716667

    Article  CAS  PubMed  Google Scholar 

  26. DM Schreinemachers RB Everson (1994) ArticleTitleAspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 IssueID2 138–146 Occurrence Handle1:STN:280:ByuB38jhsFU%3D Occurrence Handle8172988

    CAS  PubMed  Google Scholar 

  27. PF Coogan SR Rao L Rosenberg JR Palmer BL Strom AG Zauber et al. (1999) ArticleTitleThe relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer Prev Med 29 IssueID2 72–76 Occurrence Handle10.1006/pmed.1999.0518 Occurrence Handle1:CAS:528:DyaK1MXltV2hsL8%3D Occurrence Handle10446030

    Article  CAS  PubMed  Google Scholar 

  28. RE Harris KK Namboodiri WB Farrar (1996) ArticleTitleNonsteroidal antiinflammatory drugs and breast cancer Epidemiology 7 IssueID2 203–205 Occurrence Handle1:STN:280:BymH3s7kvVU%3D Occurrence Handle8834563

    CAS  PubMed  Google Scholar 

  29. S Subongkot D Frame W Leslie D Drajer (2003) ArticleTitleSelective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment Pharmacotherapy 23 IssueID1 9–28 Occurrence Handle10.1592/phco.23.1.9.31916 Occurrence Handle12523457

    Article  PubMed  Google Scholar 

  30. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94(4): 252–266

  31. Gupta RA, DuBois RN. Aspirin, NSAIDS, and colon cancer prevention: mechanisms? Gastroenterology 114(5): 1095–1098

  32. Shiff SJ, Rigas B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med 190(4): 445–450

  33. JR Cerhan KE Anderson CA Janney CM Vachon TE Witzig TM Habermann (2003) ArticleTitleAssociation of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin’s lymphoma Int J Cancer 106 IssueID5 784–788 Occurrence Handle10.1002/ijc.11311 Occurrence Handle1:CAS:528:DC%2BD3sXms1Wjsrk%3D Occurrence Handle12866040

    Article  CAS  PubMed  Google Scholar 

  34. I Kato KL Koenig RE Shore MS Baptiste PP Lillquist G Frizzera et al. (2000) ArticleTitleUse of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin’s lymphoma (NHL) (United States) Cancer Causes Control 13 IssueID10 965–974 Occurrence Handle10.1023/A:1021953224822

    Article  Google Scholar 

  35. L Bernstein RK Ross (1992) ArticleTitlePrior medication use and health history as risk factors for non-Hodgkin’s lymphoma: preliminary results from a case-control study in Los Angeles County Cancer Res 52 IssueID19 Suppl 5510s–5515s Occurrence Handle1:STN:280:ByyD3cjptFM%3D Occurrence Handle1394165

    CAS  PubMed  Google Scholar 

  36. AB Beiderbeck EA Holly MC Sturkenboom JW Coebergh BH Stricker HG Leufkens (2003) ArticleTitlePrescription medications associated with a decreased risk of non-Hodgkin’s lymphoma Am J Epidemiol 157 IssueID6 510–516 Occurrence Handle10.1093/aje/kwg004 Occurrence Handle12631540

    Article  PubMed  Google Scholar 

  37. EA Holly C Lele PM Bracci MS McGrath (1999) ArticleTitleCase-control study of non-Hodgkin’s lymphoma among women and heterosexual men in the San Francisco Bay Area, California Am J Epidemiol 150 IssueID4 375–389 Occurrence Handle1:STN:280:DyaK1MzotFKitQ%3D%3D Occurrence Handle10453814

    CAS  PubMed  Google Scholar 

  38. L Hardell M Eriksson (1999) ArticleTitleA case-control study of non-Hodgkin lymphoma and exposure to pesticides Cancer 85 IssueID6 1353–1360 Occurrence Handle10.1002/(SICI)1097-0142(19990315)85:6<1353::AID-CNCR19>3.0.CO;2-1 Occurrence Handle1:STN:280:DyaK1M3gtlShtw%3D%3D Occurrence Handle10189142

    Article  CAS  PubMed  Google Scholar 

  39. U Rannug JA Holme JK Hongslo R Sram (1995) ArticleTitleInternational Commission for Protection against Environmental Mutagens and Carcinogens. An evaluation of the genetic toxicity of paracetamol Mutation Research 327 IssueID1–2 179–200 Occurrence Handle1:CAS:528:DyaK2MXjvVelt7g%3D Occurrence Handle7870087

    CAS  PubMed  Google Scholar 

  40. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1990) Paracetamol (acetaminophen). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans pp. 307–332, Vol 50

  41. B Meibohm I Beierle H Derendorf (2002) ArticleTitleHow important are gender differences in pharmokinetics? Clin Pharmacokinet 41 IssueID5 329–342 Occurrence Handle1:CAS:528:DC%2BD38Xlt1GjtbY%3D Occurrence Handle12036391

    CAS  PubMed  Google Scholar 

  42. DR Abernethy M Divoll DJ Greenblatt B Ameer (1982) ArticleTitleObesity, sex, and acetaminophen disposition Clin Pharmacol Therapeut 31 IssueID6 783–790 Occurrence Handle1:CAS:528:DyaL38XkvVClt7g%3D

    CAS  Google Scholar 

  43. Miners JO, Grgurinovich N, Whitehead AG, Robson RA, Birkett␣DJ. Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. Brit J Clin Pharmacol 22(2): 135–142

  44. DR Abernethy M Divoll HR Ochs B Ameer DJ Greenblatt (1982) ArticleTitleIncreased metabolic clearance of acetaminophen with oral contraceptive use Obstet Gynecol 60 IssueID3 338–341 Occurrence Handle1:CAS:528:DyaL38XmtVylu7o%3D Occurrence Handle6897933

    CAS  PubMed  Google Scholar 

  45. TL Cornelison N Natarajan MS Piver CJ Mettlin (1997) ArticleTitleTubal ligation and the risk of ovarian carcinoma Cancer Detect Prev 21 IssueID1 1–6 Occurrence Handle1:STN:280:ByiC1Mnms1M%3D Occurrence Handle9043756

    CAS  PubMed  Google Scholar 

  46. O Suh C Mettlin NJ Petrelli (1993) ArticleTitleAspirin use, cancer, and polyps of the large bowel Cancer 72 IssueID4 1171–1177 Occurrence Handle1:STN:280:ByyA3sflvFM%3D Occurrence Handle8339210

    CAS  PubMed  Google Scholar 

  47. C Mettlin I Croghan N Natarajan W Lane (1990) ArticleTitleThe association of age and familial risk in a case-control study of breast cancer Am J Epidemiol 131 IssueID6 973–983 Occurrence Handle1:STN:280:By%2BB287ntVc%3D Occurrence Handle2343868

    CAS  PubMed  Google Scholar 

  48. C Mettlin N Natarajan R Huben (1990) ArticleTitleVasectomy and prostate cancer risk Am J Epidemiol 132 IssueID6 1056–1061 Occurrence Handle1:STN:280:By6D1c3nvVQ%3D Occurrence Handle2260537

    CAS  PubMed  Google Scholar 

  49. C Mettlin (1989) ArticleTitleMilk drinking, other beverage habits, and lung cancer risk Int J Cancer 43 IssueID4 608–612 Occurrence Handle1:STN:280:BiaC1MjjvVQ%3D Occurrence Handle2703270

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kirsten B. Moysich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baker, J.A., Weiss, J.R., Czuczman, M.S. et al. Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 16, 301–308 (2005). https://doi.org/10.1007/s10552-004-3074-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-004-3074-9

Keywords

Navigation